Only about one in nine U.S. adults with Medicare coverage have dental insurance, and many of them may be putting off oral healthcare as a result, a recent study suggests.
Americans are dying from heart disease at a faster rate, stalling four decades of gains against the nation’s leading killer and driving up the U.S. mortality rate overall.
People with acute coronary syndrome caused by poor blood flow to the heart may be at an increased risk of suicide - especially in the six months following their diagnosis, according to a new study from Taiwan.
People whose brains work the hardest when they try to walk and talk at the same time may have a higher risk of falling in the future than seniors who can do both with ease, a new study suggests.
Texas could be the epicenter for the nation's next major fight over stricter requirements for immunizations as rates of schoolchildren who refuse shots for non-medical reasons climb in America's second-largest state.
In New York City, 14 infants have tested positive for Zika virus, five of which have shown evidence of what’s being called congenital Zika virus syndrome.
A Pittsburgh man and woman are facing charges after their 2-month-old baby was allegedly revived by the rescue drug Narcan and tested positive for methadone.
I believe that President-elect Donald Trump will succeed in bringing down health care costs, and tackling soaring drug prices will be at the forefront of his battle.
GNC Holdings Inc, the largest global dietary supplement retailer, has agreed to pay $2.25 million and reform its practices in a pact to avoid federal prosecution over its alleged sale of illegal dietary supplements, the U.S. Department of Justice said on Wednesday.
Next time you hand your baby a teething ring to soothe her aching gums, you may be unwittingly exposing her to endocrine-disrupting chemicals (EDCs) and potentially affecting her development, new research published Wednesday in the journal Environmental Science & Technology suggests.
Dozens of children and their families took to the skies Tuesday in a special flight over Vermont to help them kick off the holiday season and forget about their illnesses for the day.
Johnson & Johnson will challenge the fairness of a trial that produced a verdict of $1 billion in damages against the company last week over allegations of design flaws in its Pinnacle hip implant.
Bristol-Myers Squibb's immunotherapy drug Opdivo has been approved in Europe for the treatment of classical Hodgkin lymphoma, a rare blood cancer, the U.S. company said on Wednesday.